Tuberous Sclerosis
"Tuberous Sclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
Descriptor ID |
D014402
|
MeSH Number(s) |
C04.445.810 C04.651.800 C04.700.632 C10.500.507.875 C10.562.850 C10.574.500.865 C16.131.666.507.875 C16.320.400.880 C16.320.700.636
|
Concept/Terms |
Tuberous Sclerosis- Tuberous Sclerosis
- Sclerosis, Tuberous
- Bourneville Syndrome
- Syndrome, Bourneville
- Bourneville's Disease
- Bourneville's Syndrome
- Bournevilles Syndrome
- Syndrome, Bourneville's
- Tuberose Sclerosis
- Bourneville-Pringle's Disease
- Bourneville Pringle's Disease
- Bourneville-Pringles Disease
- Disease, Bourneville-Pringle's
- Epiloia
- Epiloias
- Phacomatosis, Bourneville
- Bourneville Phacomatosis
- Phakomatosis, Bourneville
- Bourneville Phakomatosis
- Tuberous Sclerosis Complex
- Tuberous Sclerosis Complices
- Bourneville Disease
- Bourneville-Pringle Disease
- Bourneville Pringle Disease
- Disease, Bourneville-Pringle
Adenoma Sebaceum- Adenoma Sebaceum
- Adenoma Sebaceums
- Sebaceum, Adenoma
- Sebaceums, Adenoma
|
Below are MeSH descriptors whose meaning is more general than "Tuberous Sclerosis".
Below are MeSH descriptors whose meaning is more specific than "Tuberous Sclerosis".
This graph shows the total number of publications written about "Tuberous Sclerosis" by people in UAMS Profiles by year, and whether "Tuberous Sclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 | 2022 | 5 | 0 | 5 | 2021 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2018 | 2 | 0 | 2 | 2017 | 4 | 0 | 4 | 2016 | 2 | 0 | 2 | 2015 | 2 | 0 | 2 | 2013 | 1 | 0 | 1 | 2011 | 2 | 0 | 2 | 2008 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 | 1999 | 2 | 0 | 2 | 1992 | 1 | 0 | 1 | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tuberous Sclerosis" by people in Profiles over the past ten years.
-
Samanta D. Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy Behav. 2024 Dec; 161:110123.
-
Ghassib I, Zhang H, Qi S, Moshen R, Mishina Y, Bellido T, Liu F. Off-target activity of the 8?kb Dmp1-Cre results in the deletion of?Tsc1?gene in mouse intestinal mesenchyme. Transgenic Res. 2023 04; 32(1-2):135-141.
-
Samanta D. Reply to comments on "A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development". Epilepsy Behav. 2022 06; 131(Pt A):108704.
-
Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav. 2022 03; 128:108577.
-
Serletis D, MacDonald C, Xu Q, Kazina CJ, Dakshinamurti S, Marin S, Del Bigio MR. Hemispherectomy for hemimegalencephaly in a 6.5-week-old infant with tuberous sclerosis complex. Childs Nerv Syst. 2022 07; 38(7):1415-1419.
-
Khan M, Guzman MA, Tanios A. Story of the solitary subependymal giant cell astrocytoma: A case report and literature review. Clin Neuropathol. 2022 Jan-Feb; 41(1):6-11.
-
Bajaj G, Lindberg MR, Chee W, Samanta D, Chhabra A. Fibroma-like PEComa: a newly recognized soft tissue neoplasm in tuberous sclerosis patients-imaging features and review of literature. Skeletal Radiol. 2022 Apr; 51(4):881-887.
-
Alexander H, Govindan RB, Anwar T, Chirumamilla VC, Fayed I, Keating RF, Gaillard WD, Oluigbo CO. Global and intertuberal epileptic networks in tuberous sclerosis based on stereoelectroencephalographic (sEEG) findings: a quantitative EEG analysis in pediatric subjects and surgical implications. Childs Nerv Syst. 2022 02; 38(2):407-419.
-
Samanta D. An Updated Review of Tuberous Sclerosis Complex-Associated Autism Spectrum Disorder. Pediatr Neurol. 2020 08; 109:4-11.
-
Song X, Said Q, Tran O, Krueger DA, Bissler J. Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma. Curr Med Res Opin. 2019 06; 35(6):1103-1110.
-
Skalicky AM, Rentz AM, Liu Z, Said Q, Nakagawa JA, Frost MD, Wheless JW, Dunn DW. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families. J Med Econ. 2018 Oct; 21(10):953-959.
-
Song J, Swallow E, Said Q, Peeples M, Meiselbach M, Signorovitch J, Kohrman M, Korf B, Krueger D, Wong M, Sparagana S. Epilepsy treatment patterns among patients with tuberous sclerosis complex. J Neurol Sci. 2018 08 15; 391:104-108.
-
Bagla S, Cukovic D, Asano E, Sood S, Luat A, Chugani HT, Chugani DC, Dombkowski AA. A distinct microRNA expression profile is associated with a[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex. Neurobiol Dis. 2018 Jan; 109(Pt A):76-87.
-
Johnson MP, Johnson JC, Engel-Nitz NM, Said Q, Prestifilippo J, Gipson TT, Wheless J. Management of a Rare Disease Population: A Model for Identifying a Patient Population With Tuberous Sclerosis Complex. Manag Care. 2017 Aug; 26(8):34-41.
-
Song X, Liu Z, Cappell K, Gregory C, Said Q, Prestifilippo J, Charles H, Hulbert J, Bissler J. Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma. Curr Med Res Opin. 2017 07; 33(7):1277-1282.
-
Song X, Liu Z, Cappell K, Gregory C, Said Q, Prestifilippo J, Charles H, Hulbert J, Bissler J. Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma. J Med Econ. 2017 Apr; 20(4):388-394.
-
Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Pathol Res Pract. 2016 Nov; 212(11):972-979.
-
Wilson TA, Rodgers S, Tanweer O, Agarwal P, Lieber BA, Agarwal N, McDowell M, Devinsky O, Weiner H, Harter DH. Tuberous Sclerosis Health Care Utilization Based on the National Inpatient Sample Database: A Review of 5655 Hospitalizations. World Neurosurg. 2016 Jul; 91:97-105.
-
Samanta D. Acneiform Lesion: Importance of Detailed Skin Examination. Indian J Pediatr. 2016 May; 83(5):485-6.
-
Samanta D. Remarkable improvement of selective mutism with everolimus in a patient with tuberous sclerosis complex. Acta Neurol Belg. 2015 Dec; 115(4):815-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|